Abstract
Rational drug design is a method for developing new pharmaceuticals that typically involves the elucidation of fundamental physiological mechanisms. It thus combines the quest for a scientific understanding of natural phenomena with the design of useful technology and hence integrates epistemic and practical aims of research and development. Case studies of the rational design of the cardiovascular drugs propranolol, captopril and losartan provide insights into characteristics and conditions of this integration. Rational drug design became possible in the 1950s when theoretical knowledge of drug-target interaction and experimental drug testing could interlock in cycles of mutual advancement. The integration does not, however, diminish the importance of basic research for pharmaceutical development. Rather, it can be shown that still in the 1990s, linear processes of innovation and the close combination of practical and epistemic work were interdependent.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1016/j.shpsc.2005.07.003
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 71,410
Through your library

References found in this work BETA

Rethinking Mechanistic Explanation.Stuart Glennan - 2002 - Philosophy of Science 69 (S3):S342-S353.

Add more references

Citations of this work BETA

The Division of Cognitive Labor: Two Missing Dimensions of the Debate.Baptiste Bedessem - 2018 - European Journal for Philosophy of Science 9 (1):3.
The Division of Cognitive Labor: Two Missing Dimensions of the Debate.Baptiste Bedessem - 2018 - European Journal for Philosophy of Science 9 (1):1-16.

View all 8 citations / Add more citations

Similar books and articles

Integrating Research and Development: The Emergence of Rational Drug Design in the Pharmaceutical Industry.Matthias Adam - 2005 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 36 (3):513-537.
Institutional Mistrust in the Organization of Pharmaceutical Clinical Trials.Jill A. Fisher - 2008 - Medicine, Health Care and Philosophy 11 (4):403-413.
Industry, Innovation and Social Values.Dr Harvey E. Bale Jr - 2005 - Science and Engineering Ethics 11 (1):31-40.
Industry, Innovation and Social Values.Harvey E. Bale - 2005 - Science and Engineering Ethics 11 (1):31-40.
Interactions of Doctors with the Pharmaceutical Industry.M. A. Morgan - 2006 - Journal of Medical Ethics 32 (10):559-563.

Analytics

Added to PP index
2016-02-04

Total views
23 ( #495,433 of 2,519,873 )

Recent downloads (6 months)
3 ( #205,232 of 2,519,873 )

How can I increase my downloads?

Downloads

My notes